Wordt geladen...
Docetaxel-based chemotherapy as second-line regimen for advanced thymic carcinoma
Thymic carcinoma is an uncommon neoplasm. The efficacy of second-line treatment with docetaxel in advanced thymic carcinoma has not been well studied. Therefore, we conducted a review of the efficacy of docetaxel-based chemotherapy as a second-line regimen for advanced thymic carcinoma. Fifteen pati...
Bewaard in:
| Gepubliceerd in: | Thorac Cancer |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BlackWell Publishing Ltd
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704314/ https://ncbi.nlm.nih.gov/pubmed/26766995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12064 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|